Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Lange

Showing results (11-20 of 236) with videos related to

Pageof 24
Sort By:
Journal of Biological Regulators and Homeostatic Agents|July 1, 1995
A clinician's perspective: when to start antiretroviral treatment and when to change therapyJ S Montaner, J M Lange
Nederlands Tijdschrift Voor Geneeskunde|August 24, 2006
[The use of the non-nucleoside reverse transcriptase inhibitors nevirapine and efavirenz in the treatment of patients with a chronic HIV-I infection]F van Leth, J M Lange
Lancet (London, England)|March 7, 1992
HIV-1 sensitivity to zidovudine and clinical outcomeC A Boucher, J M Lange
Antiviral Therapy|August 1, 1996
Can HIV infection be cured?J M Lange, D D Richman
Antiviral Therapy|July 1, 1997
The first blow is half the battleJ M Lange, D D Richman
AIDS (London, England)|January 1, 1993
AIDS 92/93. Clinical treatment: overviewJ M Lange, M L Tapper
AIDS (London, England)|June 20, 1998
New antiretrovirals and new combinationsD V Havlir, J M Lange
Journal of the International Association of Physicians in AIDS Care|August 1, 1995
Highlights of the Fourth International Workshop on HIV Drug ResistanceJ M Lange, M D deJong
Antiviral Therapy|December 1, 1996
Playing with evolution requires planningD D Richman, J M Lange
Clinics in Dermatology|January 1, 1991
Serologic and immunologic markers in the course of HIV-1 infectionF de Wolf, J M Lange
Pageof 24

Showing results (11-20 of 236) with videos related to

Sort By:
Pageof 24
Journal of Biological Regulators and Homeostatic Agents|July 1, 1995
A clinician's perspective: when to start antiretroviral treatment and when to change therapyJ S Montaner, J M Lange
Nederlands Tijdschrift Voor Geneeskunde|August 24, 2006
[The use of the non-nucleoside reverse transcriptase inhibitors nevirapine and efavirenz in the treatment of patients with a chronic HIV-I infection]F van Leth, J M Lange
Lancet (London, England)|March 7, 1992
HIV-1 sensitivity to zidovudine and clinical outcomeC A Boucher, J M Lange
Antiviral Therapy|August 1, 1996
Can HIV infection be cured?J M Lange, D D Richman
Antiviral Therapy|July 1, 1997
The first blow is half the battleJ M Lange, D D Richman
AIDS (London, England)|January 1, 1993
AIDS 92/93. Clinical treatment: overviewJ M Lange, M L Tapper
AIDS (London, England)|June 20, 1998
New antiretrovirals and new combinationsD V Havlir, J M Lange
Journal of the International Association of Physicians in AIDS Care|August 1, 1995
Highlights of the Fourth International Workshop on HIV Drug ResistanceJ M Lange, M D deJong
Antiviral Therapy|December 1, 1996
Playing with evolution requires planningD D Richman, J M Lange
Clinics in Dermatology|January 1, 1991
Serologic and immunologic markers in the course of HIV-1 infectionF de Wolf, J M Lange
Pageof 24